572 related articles for article (PubMed ID: 23257155)
1. Lung cancer screening gets risk-specific.
Peres J
J Natl Cancer Inst; 2013 Jan; 105(1):1-2. PubMed ID: 23257155
[No Abstract] [Full Text] [Related]
2. Risks of PSA screening now better understood.
Peres J
J Natl Cancer Inst; 2013 Nov; 105(21):1590-2. PubMed ID: 24142893
[No Abstract] [Full Text] [Related]
3. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
4. Save your life: cancer screening is oversold. Know the tests to get--and those to skip.
Consum Rep; 2013 Mar; 78(3):28-33. PubMed ID: 23556197
[No Abstract] [Full Text] [Related]
5. Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.
Belpomme D; Irigaray P
J Natl Cancer Inst; 2010 Apr; 102(7):506-7. PubMed ID: 20190186
[No Abstract] [Full Text] [Related]
6. Screening for cervical cancer: recommendation statement.
U.S. Preventive Services Task Force
Am Fam Physician; 2012 Sep; 86(6):555-9. PubMed ID: 23062047
[No Abstract] [Full Text] [Related]
7. [Systematic PSA screening has been tried in Region Skåne. Balanced information gives chance for equal treatment according to a pilot project].
Bratt O; Lundgren R; Ahlgren G
Lakartidningen; 2012 Sep 12-18; 109(37):1610-2. PubMed ID: 23077769
[No Abstract] [Full Text] [Related]
8. Screening for prostate cancer: prostate-specific antigen testing is not effective.
Hitzeman N; Molina M
Am Fam Physician; 2011 Apr; 83(7):802-4. PubMed ID: 21524045
[No Abstract] [Full Text] [Related]
9. Solving the overdiagnosis dilemma.
Esserman L; Thompson I
J Natl Cancer Inst; 2010 May; 102(9):582-3. PubMed ID: 20413743
[No Abstract] [Full Text] [Related]
10. Cancer screening rates in individuals with different life expectancies.
Royce TJ; Hendrix LH; Stokes WA; Allen IM; Chen RC
JAMA Intern Med; 2014 Oct; 174(10):1558-65. PubMed ID: 25133746
[TBL] [Abstract][Full Text] [Related]
11. ACS releases updated guidelines on cancer screening.
Lambert M
Am Fam Physician; 2012 Sep; 86(6):571, 576-7. PubMed ID: 23062051
[No Abstract] [Full Text] [Related]
12. Assessing mammography's benefits and harms.
Schmidt C
J Natl Cancer Inst; 2014 Apr; 106(4):dju103. PubMed ID: 24685934
[No Abstract] [Full Text] [Related]
13. [Responsible cancer screening].
Verbeek AL; van Dijck JA; Kiemeney LA; Broeders MJ
Ned Tijdschr Geneeskd; 2011; 155(45):A3934. PubMed ID: 22085573
[TBL] [Abstract][Full Text] [Related]
14. Harmonizing lung cancer screening guidelines.
Nicholas J
J Natl Cancer Inst; 2012 Oct; 104(20):1531-2. PubMed ID: 23044381
[No Abstract] [Full Text] [Related]
15. Can we stop ordering prostate-specific antigen screening tests?
Katz MH
JAMA Intern Med; 2013 May; 173(10):847-8. PubMed ID: 23588841
[No Abstract] [Full Text] [Related]
16. PSA-based screening for prostate cancer. Too many adverse effects.
Prescrire Int; 2012 Sep; 21(130):215-7. PubMed ID: 23016259
[TBL] [Abstract][Full Text] [Related]
17. There is more to life than death.
Hartzband P; Groopman J
N Engl J Med; 2012 Sep; 367(11):987-9. PubMed ID: 22970943
[No Abstract] [Full Text] [Related]
18. States renewing attention to prostate cancer.
Rossiter C
NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
[No Abstract] [Full Text] [Related]
19. ACS/ASCCP/ASCP guidelines for the early detection of cervical cancer.
Fontaine PL; Saslow D; King VJ
Am Fam Physician; 2012 Sep; 86(6):501, 506-7. PubMed ID: 23062041
[No Abstract] [Full Text] [Related]
20. Cancer screening in the United States, 2013: a review of current American Cancer Society guidelines, current issues in cancer screening, and new guidance on cervical cancer screening and lung cancer screening.
Smith RA; Brooks D; Cokkinides V; Saslow D; Brawley OW
CA Cancer J Clin; 2013; 63(2):88-105. PubMed ID: 23378235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
